Creative Touch Permanent Makeup and Aesthetics

Psychological stress degrades skin biology through three converging pathways: HPA axis activation elevates cortisol and upregulates 11β-HSD1 in skin, amplifying local glucocorticoid concentration, suppressing barrier lipid synthesis, and impairing antimicrobial peptide production; sympathetic nervous system activation releases substance P, which drives premature hair follicle catagen entry, perifollicular mast cell degranulation, and neurogenic inflammation – the biologically confirmed mechanism of stress-triggered telogen effluvium; and chronic ROS overload depletes antioxidant defences, activates MMP-1/ MMP-3 collagen degradation, and accumulates DNA damage, producing measurably accelerated skin ageing. Chronic moderate psychological stress increases skin microrelief severity by approximately 32.9% compared to mildly stressed individuals. Stress exacerbates psoriasis, atopic dermatitis, acne, and rosacea through condition-specific amplification of each condition’s existing immune pathway. The relationship is bidirectional – visible skin deterioration generates additional psychological stress, sustaining the cycle.

The skin is not a passive recipient of stress signals – it is an active participant in the body’s stress response system, expressing receptors for cortisol, catecholamines, neuropeptides, and corticotropin-releasing hormone (CRH), and capable of mounting its own peripheral HPA-equivalent response through local CRH and ACTH production. The communication between brain and skin is bidirectional: psychological stress activates cutaneous neuroimmune responses, and cutaneous signals – including pain, itch, and inflammation – feed back to the central nervous system to amplify psychological stress. This brain-skin axis is the framework within which all three pathways below operate. ^[2]

Pathway 1: HPA Axis, Cortisol, and Barrier Disruption

Perceived psychological stress activates hypothalamic neurons to secrete CRH, which stimulates pituitary ACTH release, which drives adrenal cortisol secretion. Elevated systemic cortisol inhibits keratinocyte differentiation, reduces barrier lipid synthesis ( cholesterol, ceramides, and free fatty acids in the lamellar bodies), and suppresses the cytokine signalling – particularly IL-1α and TNF-α at physiological rather than pathological levels – that normally drives barrier maintenance and repair. The result is measurably elevated TEWL and impaired barrier recovery after disruption. ^[3]

A less widely appreciated component of this pathway is peripheral cortisol amplification via 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1). This enzyme, expressed in skin keratinocytes and fibroblasts, converts cortisone (the inactive circulating form) back to cortisol locally – meaning that psychological stress elevates not only systemic cortisol but also the enzymatic capacity of the skin to generate active glucocorticoid from the circulating inactive precursor. Under psychological stress, 11β-HSD1 expression increases in skin, amplifying the local cortisol concentration beyond what systemic levels alone would predict. ^[3] This peripheral amplification mechanism is why the skin consequences of chronic stress can be disproportionate to the measured systemic cortisol level – the skin is generating its own cortisol excess on top of the systemic load.

Cortisol additionally suppresses antimicrobial peptide production – particularly cathelicidin (LL-37) and β-defensins – reducing the skin’s defence against microbial colonisation. This provides a mechanistic link between psychological stress and increased susceptibility to cutaneous infections, documented in clinical and experimental models. jci.org

Pathway 2: Substance P, Neuropeptides, and Hair Follicle Disruption

Parallel to the HPA axis, psychological stress activates the sympathetic nervous system, which releases catecholamines (adrenaline, noradrenaline) and drives the release of neuropeptides – particularly substance P – from peripheral sensory nerve endings in the skin and perifollicular dermis. Substance P acts on NK1 receptors expressed on hair follicle keratinocytes, perifollicular mast cells, and dermal papilla cells, producing a cluster of hair growth-inhibitory effects that collectively constitute a biologically plausible mechanism for stress-triggered telogen effluvium.

The pathophysiology involves four converging substance P-mediated events: downregulation of pro-proliferative signalling in hair follicle keratinocytes; mast cell degranulation and perifollicular neurogenic inflammation that creates a hostile perifollicular environment; activation of catagen-inducing growth factor cascades that prematurely terminate the anagen (growth) phase; and impairment of the immune privilege of the hair follicle epithelium, potentially recruiting an immune attack on the follicle. ^[4] In murine models, psychoemotional stress produces premature catagen entry – early termination of active hair growth – through substance P-dependent pathways; substance P receptor antagonism blocks the effect, providing both mechanistic confirmation and a potential therapeutic target. ^[1]

The clinical implication for aesthetics practice is that a client presenting with diffuse hair shedding in the context of a period of significant psychological stress has a biologically coherent causal pathway – not merely a correlation – and that the shedding pattern (diffuse, delayed 2–3 months after the stressor, spontaneously resolving as stress reduces) is consistent with stress-triggered telogen effluvium rather than androgenetic alopecia or nutritional deficiency. The distinction matters for treatment approach, and for setting accurate expectations about timeline.

Pathway 3: Oxidative Stress, ROS, and Accelerated Skin Ageing

Chronic psychological stress elevates circulating catecholamines and cortisol in a sustained pattern that generates reactive oxygen species (ROS) through mitochondrial respiratory chain overload and NADPH oxidase activation. ROS damage cellular DNA, lipid membranes, and ECM proteins; they also activate the transcription factor AP-1, which upregulates MMP-1 and MMP-3 – the same collagenolytic metalloproteinases driven by UV exposure and TNF-α. ^[2] The antioxidant defence system – glutathione, superoxide dismutase, catalase – is progressively depleted under chronic stress, reducing the cell’s capacity to neutralise the ROS burden.

The downstream skin consequences are accelerated collagen degradation, impaired ECM synthesis, and accumulated DNA damage in keratinocytes and fibroblasts that reduces their proliferative and synthetic capacity. A 2024 clinical study confirmed these mechanisms translate to measurable skin ageing outcomes: chronically moderately stressed individuals showed significantly decreased antioxidant potential, impaired barrier integrity, and approximately 32.9% more severe microrelief alterations (fine lines, texture) than mildly stressed individuals matched for other variables. ^[5]

Stress as an Exacerbating Factor in Skin Conditions

Psychological stress does not cause inflammatory skin conditions in isolation, but it reliably exacerbates them by amplifying the immune dysregulation that underlies each. The mechanism differs by condition:

• Psoriasis: Stress activates the HPA axis and increases substance P release, amplifying the Th17/IL-17 inflammatory loop already present in psoriatic skin; clinical flares following stressful life events are well-documented
• Atopic dermatitis: Stress-driven cortisol further suppresses filaggrin expression on top of the existing IL-4/ IL-13-mediated suppression, compounding barrier failure; substance P activates mast cell degranulation, worsening itch
• Acne: Adrenal androgen production rises with stress via ACTH stimulation, increasing sebum output and promoting comedone formation; CRH stimulates sebocyte lipid synthesis directly via CRH-R1 receptors on sebaceous glands
• Rosacea: Catecholamine-driven vascular reactivity amplifies the facial flushing and erythema of rosacea; stress is a consistently reported patient-identified trigger

The Bidirectional Cycle

The clinical importance of bidirectionality is its compounding effect over time. Psychological stress degrades skin quality → visible skin deterioration ( hair loss, barrier compromise, accelerated ageing, inflammatory flares) generates additional psychological stress about appearance → this stress further activates the HPA axis and substance P pathways → further skin deterioration. In clients presenting with appearance-related distress, this cycle may be actively self-sustaining – meaning that aesthetic treatment addressing the visible concern can interrupt the cycle at one point, reducing the psychological load that was driving the biological deterioration. This is not a superficial justification for cosmetic treatment; it is a mechanistically coherent rationale for why treating the visible skin consequence of stress can produce health benefits beyond the cosmetic.